What is the best pharmacologic treatment for sickle cell disease pain crises? (отваря нов прозорец)

Baker M, Hafner JW.

Източник‎: Ann Emerg Med 2012;59(6):515-6.

Статията е индексирана‎: PubMed 22221839

DOI‎: 10.1016/j.annemergmed.2011.11.026

https://www.ncbi.nlm.nih.gov/pubmed/22221839 (отваря нов прозорец)

Multi-modal intervention and prospective implementation of standardized sickle cell pain admission orders reduces 30-day readmission rate. (отваря нов прозорец)

Frei-Jones MJ, Field JJ, DeBaun MR.

Източник‎: Pediatr Blood Cancer 2009;53(3):401-5.

Статията е индексирана‎: PubMed 19422031

DOI‎: 10.1002/pbc.22048

https://www.ncbi.nlm.nih.gov/pubmed/19422031 (отваря нов прозорец)

Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. (отваря нов прозорец)

Qari MH, Aljaouni SK, Alardawi MS, Fatani H, Alsayes FM, Zografos P, Alsaigh M, Alalfi A, Alamin M, Gadi A, Mousa SA.

Източник‎: Thromb Haemost 2007;98(2):392-6.

Статията е индексирана‎: PubMed 17721622

https://www.ncbi.nlm.nih.gov/pubmed/17721622 (отваря нов прозорец)

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. (отваря нов прозорец)

Okomo U, Meremikwu MM.

Източник‎: Cochrane Database Syst Rev 2012;(6):CD005406.

Статията е индексирана‎: PubMed 22696351

DOI‎: 10.1002/14651858.CD005406.pub3

https://www.ncbi.nlm.nih.gov/pubmed/22696351 (отваря нов прозорец)

Guidelines for the management of the acute painful crisis in sickle cell disease. (отваря нов прозорец)

Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party.

Източник‎: Br J Haematol 2003;120(5):744-52.

Статията е индексирана‎: PubMed 12614204

https://www.ncbi.nlm.nih.gov/pubmed/12614204 (отваря нов прозорец)

The use of incentive spirometry in pediatric patients with sickle cell disease to reduce the incidence of acute chest syndrome. (отваря нов прозорец)

Ahmad FA, Macias CG, Allen JY.

Източник‎: J Pediatr Hematol Oncol 2011;33(6):415-20.

Статията е индексирана‎: PubMed 21792036

DOI‎: 10.1097/MPH.0b013e31821ed4ce

https://www.ncbi.nlm.nih.gov/pubmed/21792036 (отваря нов прозорец)

Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. (отваря нов прозорец)

Ballas SK, Files B, Luchtman-Jones L, Benjamin L, Swerdlow P, Hilliard L, Coates T, Abboud M, Wojtowicz-Praga S, Grindel JM.

Източник‎: Hemoglobin 2004;28(2):85-102.

Статията е индексирана‎: PubMed 15182051

https://www.ncbi.nlm.nih.gov/pubmed/15182051 (отваря нов прозорец)

Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. (отваря нов прозорец)

Bernini JC, Rogers ZR, Sandler ES, Reisch JS, Quinn CT, Buchanan GR.

Източник‎: Blood 1998;92(9):3082-9.

Статията е индексирана‎: PubMed 9787142

https://www.ncbi.nlm.nih.gov/pubmed/9787142 (отваря нов прозорец)

A short course of prednisone in the management of acute chest syndrome of sickle cell disease. (отваря нов прозорец)

Kumar R, Qureshi S, Mohanty P, Rao SP, Miller ST.

Източник‎: J Pediatr Hematol Oncol 2010;32(3):e91-4.

Статията е индексирана‎: PubMed 20216237

DOI‎: 10.1097/MPH.0b013e3181c29c52

https://www.ncbi.nlm.nih.gov/pubmed/20216237 (отваря нов прозорец)

A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. (отваря нов прозорец)

Morris CR, Kuypers FA, Lavrisha L, Ansari M, Sweeters N, Stewart M, Gildengorin G, Neumayr L, Vichinsky EP.

Източник‎: Haematologica 2013;98(9):1375-82.

Статията е индексирана‎: PubMed 23645695

DOI‎: 10.3324/haematol.2013.086637

https://www.ncbi.nlm.nih.gov/pubmed/23645695 (отваря нов прозорец)

Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. (отваря нов прозорец)

Weiner DL, Hibberd PL, Betit P, Cooper AB, Botelho CA, Brugnara C.

Източник‎: JAMA 2003;289(9):1136-42.

Статията е индексирана‎: PubMed 12622584

https://www.ncbi.nlm.nih.gov/pubmed/12622584 (отваря нов прозорец)

Predictors of bacteremia in febrile children with sickle cell disease. (отваря нов прозорец)

West DC, Andrada E, Azari R, Rangaswami AA, Kuppermann N.

Източник‎: J Pediatr Hematol Oncol 2002;24(4):279-83.

Статията е индексирана‎: PubMed 11972096

https://www.ncbi.nlm.nih.gov/pubmed/11972096 (отваря нов прозорец)